NOS1 and Alzheimer disease: All three NOS isoforms show aberrant patterns of expression in AD, altering intracellular signaling and routing oxidative stress in directions that are uncompounded [26]; however, data indicating changes in the NOS1 level and their involvement in amplifying or reducing neuronal damage are inconsistent, and to some degree, contradictory.